Blueprint Medicines Statistics
Total Valuation
FRA:1AC has a market cap or net worth of EUR 4.29 billion.
Market Cap | 4.29B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Tuesday, July 22, 2025.
Earnings Date | Jul 22, 2025 |
Ex-Dividend Date | May 14, 2025 |
Share Statistics
Current Share Class | 51.71M |
Shares Outstanding | n/a |
Shares Change (YoY) | +1.32% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 27.03M |
Valuation Ratios
The trailing PE ratio is 13.04 and the forward PE ratio is 7.27.
PE Ratio | 13.04 |
Forward PE | 7.27 |
PS Ratio | 1.41 |
PB Ratio | 1.25 |
P/TBV Ratio | 1.29 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 4.61.
Current Ratio | 0.91 |
Quick Ratio | 0.38 |
Debt / Equity | 4.61 |
Debt / EBITDA | n/a |
Debt / FCF | -11.55 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.05%.
Return on Equity (ROE) | 10.05% |
Return on Assets (ROA) | 1.69% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 636,325 |
Profits Per Employee | 68,883 |
Employee Count | 4,455 |
Asset Turnover | 0.16 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:1AC has paid 14.75 million in taxes.
Income Tax | 14.75M |
Effective Tax Rate | 4.29% |
Stock Price Statistics
The stock price has decreased by -12.15% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -12.15% |
50-Day Moving Average | 82.60 |
200-Day Moving Average | 90.18 |
Relative Strength Index (RSI) | 47.02 |
Average Volume (20 Days) | 30 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.35 |
Income Statement
In the last 12 months, FRA:1AC had revenue of EUR 3.04 billion and earned 329.19 million in profits. Earnings per share was 6.15.
Revenue | 3.04B |
Gross Profit | 2.77B |
Operating Income | 345.25M |
Pretax Income | 343.94M |
Net Income | 329.19M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | 6.15 |
Balance Sheet
The company has 291.92 million in cash and 15.83 billion in debt, giving a net cash position of -15.54 billion.
Cash & Cash Equivalents | 291.92M |
Total Debt | 15.83B |
Net Cash | -15.54B |
Net Cash Per Share | n/a |
Equity (Book Value) | 3.43B |
Book Value Per Share | 66.45 |
Working Capital | -1.13B |
Cash Flow
In the last 12 months, operating cash flow was -1.37 billion and capital expenditures -1.76 million, giving a free cash flow of -1.37 billion.
Operating Cash Flow | -1.37B |
Capital Expenditures | -1.76M |
Free Cash Flow | -1.37B |
FCF Per Share | n/a |
Margins
Gross margin is 90.95%, with operating and profit margins of 11.35% and 10.83%.
Gross Margin | 90.95% |
Operating Margin | 11.35% |
Pretax Margin | 11.31% |
Profit Margin | 10.83% |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.12, which amounts to a dividend yield of 1.41%.
Dividend Per Share | 1.12 |
Dividend Yield | 1.41% |
Dividend Growth (YoY) | 50.87% |
Years of Dividend Growth | 1 |
Payout Ratio | 16.08% |
Buyback Yield | -1.32% |
Shareholder Yield | 0.08% |
Earnings Yield | 7.67% |
FCF Yield | -31.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |